Trial · NCT06168409
A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension
NCT06168409, Phase 3, Completed, AstraZeneca
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension. Trials, record NCT06168409. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06168409
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension
- NCT number
- NCT06168409
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 218 participants, actual
- Lead sponsor
- AstraZeneca
- Conditions
- Resistant Hypertension
- Interventions
- Baxdrostat, Placebo
- First posted
- 2023-12-13
- Last updated
- 2026-08-06
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Least Square Mean Difference for Change From Baseline in Ambulatory 24-hour Average SBP at Week 12: Treatment Policy Strategy | Baseline to week 12 | |
| Secondary | Change From Baseline in Ambulatory Night-time Average SBP (mmHg) at Week 12 LS Means | Baseline to week 12 | |
| Secondary | Change From Baseline in Ambulatory Daytime Average SBP (mmHg) at Week 12 | Baseline to week 12 | |
| Secondary | Change From Baseline in Seated SBP (mmHg) at Week 12 | Baseline to week 12 | |
| Secondary | Achieving Ambulatory 24-hour Average SBP of < 130 mmHg at Week 12 | Baseline to week 12 | |
| Secondary | Change From Baseline in Ambulatory 24-hour Average DBP (mmHg) at Week 12 | Baseline to week 12 | |
| Secondary | Change From Baseline in Ambulatory Night-time Average DBP (mmHg) at Week 12 | Baseline to week 12 | |
| Secondary | Change From Baseline in Ambulatory Daytime Average DBP (mmHg) at Week 12 | Baseline to week 12 | |
| Secondary | Change From Baseline in Seated DBP (mmHg) at Week 12 | Baseline to week 12 | |
| Secondary | Achieving a Nocturnal SBP Dipping of >= 10% at Week 12 | Baseline to week 12 |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06168409
GET https://conductscience.org/api/trials/v1/NCT06168409/registered